Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
FDA Oncology
Mar 15, 2024, 18:14 |
Blog
Vivek Subbiah: 'Tissue-Agnostic Cancer Therapy Approvals' now published as a book chapter in 'Precision Oncology and Cancer Surgery'
Vivek Subbiah shared a post on LinkedIn: "Guess what arrived in my office today hot…
Mar 11, 2024, 21:06 |
Blog
Vivek Subbiah: It’s the best time to work in oncology drug development
Vivek Subbiah recently shared on LinkedIn: “It’s the best time to work in oncology drug development!…
Mar 8, 2024, 19:56 |
Insight
Vivek Subbiah: How can we Modernize Precision Oncology With Decentralized Trial Tools?
Vivek Subbiah recently shared on LinkedIn: "Precision oncology has seen exciting developments in recent years with…
Mar 7, 2024, 17:07 |
Blog
Vivek Subbiah: It was such a delight to be at the Precision Oncology WIN Symposium 2024
Vivek Subbiah shared a post on X: "It was such a delight to be at the…
Mar 6, 2024, 11:34 |
Drugs
Rami Manochakian: U.S. FDA approves Amivantamab WITH CHEMOTHERAPY for 1st Line treatment of advanced non-small cell Lung Cancer with EGFR
Rami Manochakian, Hematology-Oncology Fellowship Director at Mayo Clinic, shared on X/Twitter: “HOT OFF THE PRESS…
Feb 23, 2024, 11:08 |
Insight
Provides an overview of oncology drugs approved the previous year - Nature Reviews Clinical Oncology
Nature Reviews Clinical Oncology shared a post on X: "One more year FDA Oncology provides an…
Feb 21, 2024, 18:18 |
Insight
Vivek Subbiah: As of December 31, 2023, the FDA had become aware of 22 cases of T-cell cancers that occurred after treatment with CAR-T products
Vivek Subbiah shared on LinkedIn: "Perspective article on 'Secondary Cancers after Chimeric Antigen Receptor T-Cell…
Feb 17, 2024, 17:47 |
Insight
Vivek Subbiah: Delighted to share Modernize Precision Oncology With Decentralized Trial Tools
Vivek Subbiah shared a post on X: "Hot off the press JAMA Oncology: Delighted to…
Feb 17, 2024, 16:27 |
Drugs
Tanja Obradovic: BioXcel Therapeutics received Fast Track designation by the FDA for BXCL701
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, shared on LinkedIn: "Biotech companies…
Feb 17, 2024, 15:57 |
Insight
Rami Manochakian: The FDA approves 1st line Osimertinib WITH chemotherapy for advanced EGFRm NSCLC.
Rami Manochakian, Thoracic Oncologist and Hematology-Oncology Fellowship Director at Mayo Clinic, shared on X/Twitter: "Hot off…
15
16
17
18
19
All:
562
Posts:
161 - 170
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024
Uniting Forces: Leveraging Cancer Research to Revolutionize Tuberculosis Treatment
World - first lung cancer vaccine trials launched across 7 countries
Lance Armstrong and Testicular Cancer: Story, Symptoms, Treatment
Honoring Jeff Weber, a giant in the field of oncology
Facebook
RSS Feed
Twitter
Linkedin
Youtube